Generics 1

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Zinc chloride manufacturers

1 products found

Filters

Filters

Filters , active

Country of origin : Australia

Clear all

1 products found

zinc chloride

Solution for injection 10.6 mg in 2 mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Australia
GMP approvals
TGA
Manufacturer #13731
It is a European-owned company dedicated to providing training and job opportunities in the domains of research and development as well as commercial product production for both domestic and international markets. Over 65 drugs in essential therapeutic areas are supplied by them. It also sells and licenses items all over the world, including the Pacific, Asia, Europe, Canada, the Americas, and the Middle East

Manufacturer usually replies in 9 days

Want to see all 1 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Zinc chloride is a mineral that is used pharmaceutically as a disinfection agent and astringent agent. Manufacturing companies produce medications both with zinc chloride as the standalone ingredient, as well as use it as a constituent in combination medications along with other active ingredients, such as ethanol, hyaluronic acid, benzocaine, and levomenthol. Suppliers primarily market zinc chloride medications in the forms of dental solutions as well as a wide range of topical solutions, such as gels, lotions, creams, sprays, and others.

Interested in becoming a subscriber?

Please provide the following information to receive an offer tailored to your business needs

  1. Number of company users for the subscription
  2. The rough number of products you would like to source in the 12 months
  3. Target market(s) for commercialisation